Dyssynchronous Fetal Heart Failure in Maternal Diabetes: Evaluation with Speckle Tracking Echocardiography and Novel M-Mode Software.

Theresa M Kühle¹, Angela Burgmair², Georg Schummers³, Mareike Möllers⁴, Kathrin Oelmeier⁴, Chiara De Santis⁴, Helen Ann Köster⁵, Ute Möllmann⁴, Daniela Willy⁴, Janina Braun⁴, Felix Albert⁶, Ralf Schmitz⁴

¹University Hospital Münster, Clinic of Obstetrics and Gynecology, Münster, Germany. Electronic address: tkuehle@uni-muenster.de.

²Research Group Medical Technologies, Universities of Applied Sciences, Landshut, Germany; TOMTEC Imaging Systems GmbH, Unterschleissheim, Germany.

³TOMTEC Imaging Systems GmbH, Unterschleissheim, Germany.

⁴University Hospital Münster, Clinic of Obstetrics and Gynecology, Münster, Germany.

⁵Gynecological practice, Frauenaerztin am Mexikoplatz, Berlin, Germany.

⁶Institute of Biostatistics and Clinical Research, Münster, Germany.

PubMed DOI

Abstract

OBJECTIVES: This study aimed to investigate dyssynchronous heart failure in fetuses of mothers with diabetes mellitus (FDM) and fetal controls (FC) using two-dimensional speckle tracking echocardiography (2D-STE) and novel M-mode prototype software (PS). METHODS: In this cohort study 174 fetuses were analyzed, 87 in the FDM-cohort and 87 gestational age-matched fetuses in the FC-cohort. A subgrou…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.